Literature DB >> 29253717

Regulation of ADAM10 by miR-140-5p and potential relevance for Alzheimer's disease.

Rumana Akhter1, Yvonne Shao2, McKenzie Shaw2, Shane Formica2, Maria Khrestian2, James B Leverenz3, Lynn M Bekris2.   

Abstract

Recent reports in Alzheimer's disease (AD) research suggest that alterations in microRNA (miRNA) expression are associated with disease pathology. Our previous studies suggest that A Disintegrin and Metalloproteinase 10 (ADAM10) expression is important in AD and could be modulated by an extended regulatory region that includes the 3' untranslated region. In this study, we have investigated the role of trans-acting factors in ADAM10 gene regulation. Our study shows that miRNA-140-5p has enhanced expression in the AD postmortem brain hippocampus using high-throughput miRNA arrays and quantitative real-time polymerase chain reaction. Interestingly, we have also seen that miRNA-140-5p seed sequence is present on 3' untranslated region of both ADAM10 and its transcription factor SOX2. The specific interaction of miRNA-140-5p with both ADAM10 and SOX2 signifies high regulatory importance of this miRNA in controlling ADAM10 expression. Thus, this investigation unravels mechanisms underlying ADAM10 downregulation by miR-140-5p and suggests that dysfunctional regulation of ADAM10 expression is exacerbated by AD-related neurotoxic effects. These findings underscore the importance of understanding the impact of trans-acting factors in the modulation of AD pathophysiology.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29253717      PMCID: PMC5800962          DOI: 10.1016/j.neurobiolaging.2017.11.007

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  56 in total

1.  The transcription factor PAX2 regulates ADAM10 expression in renal cell carcinoma.

Authors:  Kai Doberstein; Josef Pfeilschifter; Paul Gutwein
Journal:  Carcinogenesis       Date:  2011-08-30       Impact factor: 4.944

2.  The essential role of p53-up-regulated modulator of apoptosis (Puma) and its regulation by FoxO3a transcription factor in β-amyloid-induced neuron death.

Authors:  Rumana Akhter; Priyankar Sanphui; Subhas Chandra Biswas
Journal:  J Biol Chem       Date:  2014-02-24       Impact factor: 5.157

3.  miRNA expression profiles in cerebrospinal fluid and blood of patients with acute ischemic stroke.

Authors:  Sofie Sølvsten Sørensen; Ann-Britt Nygaard; Ming-Yuan Nielsen; Kai Jensen; Thomas Christensen
Journal:  Transl Stroke Res       Date:  2014-08-17       Impact factor: 6.829

4.  Reciprocal effects between microRNA-140-5p and ADAM10 suppress migration and invasion of human tongue cancer cells.

Authors:  Yang Kai; Wang Peng; Wu Ling; Hao Jiebing; Bian Zhuan
Journal:  Biochem Biophys Res Commun       Date:  2014-02-13       Impact factor: 3.575

Review 5.  MicroRNAs in Parkinson's disease.

Authors:  M Maral Mouradian
Journal:  Neurobiol Dis       Date:  2012-01-05       Impact factor: 5.996

6.  ADAM10 missense mutations potentiate β-amyloid accumulation by impairing prodomain chaperone function.

Authors:  Jaehong Suh; Se Hoon Choi; Donna M Romano; Moira A Gannon; Andrea N Lesinski; Doo Yeon Kim; Rudolph E Tanzi
Journal:  Neuron       Date:  2013-09-19       Impact factor: 17.173

7.  The regulation of p53 up-regulated modulator of apoptosis by JNK/c-Jun pathway in β-amyloid-induced neuron death.

Authors:  Rumana Akhter; Priyankar Sanphui; Hrishita Das; Pampa Saha; Subhas Chandra Biswas
Journal:  J Neurochem       Date:  2015-04-28       Impact factor: 5.372

8.  Leukocytes require ADAM10 but not ADAM17 for their migration and inflammatory recruitment into the alveolar space.

Authors:  Jessica Pruessmeyer; Franz Martin Hess; Henriette Alert; Esther Groth; Tobias Pasqualon; Nicole Schwarz; Stella Nyamoya; Jos Kollert; Emiel van der Vorst; Marjo Donners; Christian Martin; Stefan Uhlig; Paul Saftig; Daniela Dreymueller; Andreas Ludwig
Journal:  Blood       Date:  2014-05-15       Impact factor: 22.113

9.  Early mechanisms of pathobiology are revealed by transcriptional temporal dynamics in hippocampal CA1 neurons of prion infected mice.

Authors:  Anna Majer; Sarah J Medina; Yulian Niu; Bernard Abrenica; Kathy J Manguiat; Kathy L Frost; Clark S Philipson; Debra L Sorensen; Stephanie A Booth
Journal:  PLoS Pathog       Date:  2012-11-08       Impact factor: 6.823

10.  MicroRNAs can regulate human APP levels.

Authors:  Neha Patel; David Hoang; Nathan Miller; Sara Ansaloni; Qihong Huang; Jack T Rogers; Jeremy C Lee; Aleister J Saunders
Journal:  Mol Neurodegener       Date:  2008-08-06       Impact factor: 14.195

View more
  15 in total

1.  A Systematic Review of MicroRNA Expression as Biomarker of Late-Onset Alzheimer's Disease.

Authors:  Soraya Herrera-Espejo; Borja Santos-Zorrozua; Paula Álvarez-González; Elixabet Lopez-Lopez; África Garcia-Orad
Journal:  Mol Neurobiol       Date:  2019-06-25       Impact factor: 5.590

Review 2.  Dysregulated miRNAs in Progression and Pathogenesis of Alzheimer's Disease.

Authors:  Tania Arora; Vikash Prashar; Randeep Singh; Tushar Singh Barwal; Harish Changotra; Arti Sharma; Jyoti Parkash
Journal:  Mol Neurobiol       Date:  2022-07-22       Impact factor: 5.682

Review 3.  MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases.

Authors:  T P Nhung Nguyen; Mandeep Kumar; Ernesto Fedele; Giambattista Bonanno; Tiziana Bonifacino
Journal:  Int J Mol Sci       Date:  2022-04-25       Impact factor: 6.208

4.  MicroRNA predicts cognitive performance in healthy older adults.

Authors:  Joseph M Gullett; Zhaoyi Chen; Andrew O'Shea; Maisha Akbar; Jiang Bian; Asha Rani; Eric C Porges; Thomas C Foster; Adam J Woods; Francois Modave; Ronald A Cohen
Journal:  Neurobiol Aging       Date:  2020-08-03       Impact factor: 4.673

5.  TREM2 alters the phagocytic, apoptotic and inflammatory response to Aβ42 in HMC3 cells.

Authors:  Rumana Akhter; Yvonne Shao; Shane Formica; Maria Khrestian; Lynn M Bekris
Journal:  Mol Immunol       Date:  2021-01-15       Impact factor: 4.407

6.  Protective effect of dioscin against doxorubicin-induced cardiotoxicity via adjusting microRNA-140-5p-mediated myocardial oxidative stress.

Authors:  Lisha Zhao; Xufeng Tao; Yan Qi; Lina Xu; Lianhong Yin; Jinyong Peng
Journal:  Redox Biol       Date:  2018-03-06       Impact factor: 11.799

Review 7.  The Role of Non-coding RNAs in Alzheimer's Disease: From Regulated Mechanism to Therapeutic Targets and Diagnostic Biomarkers.

Authors:  Yuan Zhang; Yanfang Zhao; Xiang Ao; Wanpeng Yu; Lei Zhang; Yu Wang; Wenguang Chang
Journal:  Front Aging Neurosci       Date:  2021-07-02       Impact factor: 5.750

Review 8.  Alpha-Secretase ADAM10 Regulation: Insights into Alzheimer's Disease Treatment.

Authors:  Rafaela Peron; Izabela Pereira Vatanabe; Patricia Regina Manzine; Antoni Camins; Márcia Regina Cominetti
Journal:  Pharmaceuticals (Basel)       Date:  2018-01-29

Review 9.  Mitochondrial MicroRNAs in Aging and Neurodegenerative Diseases.

Authors:  Albin John; Aaron Kubosumi; P Hemachandra Reddy
Journal:  Cells       Date:  2020-05-28       Impact factor: 6.600

Review 10.  Modulation of MicroRNAs as a Potential Molecular Mechanism Involved in the Beneficial Actions of Physical Exercise in Alzheimer Disease.

Authors:  Alex Cleber Improta-Caria; Carolina Kymie Vasques Nonaka; Bruno Raphael Ribeiro Cavalcante; Ricardo Augusto Leoni De Sousa; Roque Aras Júnior; Bruno Solano de Freitas Souza
Journal:  Int J Mol Sci       Date:  2020-07-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.